Please use a PC Browser to access Register-Tadawul
Get It
NeoGenomics shares are trading lower after Natera won a preliminary injuction in a patent infringement lawsuit against NeoGenomics' RaDar test.
NeoGenomics, Inc. NEO | 11.90 | +1.88% |
